Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2026-05-01 Annual Report
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
Immediate Report
Annual Report Classification · 100% confidence The document is a Form 20-F filed with the U.S. Securities and Exchange Commission (SEC), which is an annual report for a foreign private issuer. It is explicitly titled as an "Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934" for the fiscal year ended December 31, 2025. The text includes detailed financial information, references to audited consolidated financial statements, accounting standards (IFRS), and extensive management discussion and forward-looking statements typical of an annual report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the full report, not just an announcement or certification. Therefore, the correct classification is Annual Report (10-K equivalent for foreign issuers). FY 2025
2026-05-01 English
Immediate Report
Annual Report Classification · 95% confidence The document references a '20F לשנת 2025' which translates to '20-F for the year 2025'. Form 20-F is a well-known annual report filed by foreign private issuers to the U.S. Securities and Exchange Commission, equivalent to an Annual Report (10-K) for U.S. domestic companies. The document is an immediate report under Regulation 4 of the Securities Regulations for foreign corporations, indicating it is the actual filing of the annual report rather than an announcement. The document length is 1826 characters, which is short, but the text explicitly states the attached report is the Form 20-F itself, not just an announcement of its publication. Therefore, this document should be classified as an Annual Report (10-K equivalent). FY 2025
2026-05-01 English
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
Regulatory Filings Classification · 90% confidence The document is a Form 6-K filed with the SEC by InterCure Ltd. The content of the filing is a press release regarding a Nasdaq notification of non-compliance with the minimum bid price requirement. While this relates to listing status, it is not a formal delisting announcement (which would be a final notice of removal), but rather a notification of a deficiency that the company intends to cure. Under the provided categories, this regulatory filing regarding listing status and deficiency notifications is best classified as a Regulatory Filing (RNS) as it does not fit into the specific 'Delisting' category (which implies the act of delisting) or other specific categories.
2026-03-04 English
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 2,000 characters) issued via the MAGNA system. It explicitly states 'Attached hereto is a report on...' followed by a reference to a PDF file. According to the 'Menu vs Meal' rule, a document that announces the publication of another report and provides it as an attachment is classified as a Report Publication Announcement (RPA).
2026-03-04 English
6K-Preliminary results for the full year of 2025
Earnings Release Classification · 100% confidence The document is a Form 6-K filing submitted to the U.S. SEC by InterCure Ltd. It contains a press release announcing preliminary estimated financial results for the full year 2025, including revenue and Adjusted EBITDA figures. While it contains financial data, it is explicitly labeled as 'preliminary' and serves as an initial announcement of results rather than the full audited annual report (which the text notes will be filed later on Form 20-F). Therefore, it is classified as an Earnings Release. FY 2025
2026-02-19 English
6K-Preliminary results for the full year of 2025
Regulatory Filings Classification · 95% confidence The document is a short regulatory filing (1800 characters) submitted via the MAGNA system. It explicitly states 'Attached hereto is a report on...' and provides a filename 'on_isa.pdf'. According to the 'Menu vs Meal' rule, since this is a short announcement of an attached report rather than the full report itself, it is classified as a Report Publication Announcement (RPA).
2026-02-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.